Clinical Trial Update: Abiraterone-Rechallenge Study for CRPC Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Abiraterone rechallenge in patients with castration-resistant prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: Aurelius Omlin | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED